Many Breast Cancer Survivors Do Not Undergo Annual Surveillance
MONDAY, June 4, 2018 -- A considerable proportion of breast cancer survivors do not undergo annual surveillance breast imaging, according to a study published in the May issue of the Journal of the National Comprehensive Cancer Network. Kathryn J.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2018 Category: Pharmaceuticals Source Type: news

Good news for women with breast cancer: Many don ’t need chemo
Many women with early-stage forms of the disease can forgo chemo, based on a test that measures the activity of genes involved in breast cancer recurrence. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 4, 2018 Category: Pharmaceuticals Authors: Denise Grady Source Type: news

Thousands of breast cancer patients may be SPARED from chemotherapy
A landmark study in New York has found that a significant proportion of women with the disease need only a daily pill – such as tamoxifen – to stop their cancer returning after surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

Breast cancer breakthrough: More women may avoid chemotherapy thanks to new research
BREAST cancer symptoms include a lump on the breast or a change in the breast ’s size. Treatment includes surgery, radiotherapy and chemotherapy. However, new research published yesterday has suggested chemotherapy could be avoided by many women. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

WATCH: Chemo may not be necessary for breast cancer patients: Study
A new study has found that 70 percent of early stage breast cancer patients may not need chemotherapy. ABC News' Maggie Rulli reports. (Source: ABC News: Health)
Source: ABC News: Health - June 4, 2018 Category: Consumer Health News Tags: Health Source Type: news

Breast cancer 'could be treated without facing chemotherapy'
THOUSANDS of breast cancer patients could be spared gruelling chemotherapy, a study claims. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

Chemo Not Needed for Most Early Breast Cancer
: TAILORx (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2018 Category: General Medicine Source Type: news

Gene Test May Allow Many With Early Breast Cancer to Avoid Chemo
Title: Gene Test May Allow Many With Early Breast Cancer to Avoid ChemoCategory: Health NewsCreated: 6/3/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Experimental Drug Shows 'Modest' Benefit in Slowing Advanced Breast Cancer
Title: Experimental Drug Shows 'Modest' Benefit in Slowing Advanced Breast CancerCategory: Health NewsCreated: 6/2/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Implications of BMI With Breast Cancer Tumor Size Implications of BMI With Breast Cancer Tumor Size
High BMI may be associated with having a larger tumor at diagnosis of breast cancer and worse prognosis.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients
(University of Texas M. D. Anderson Cancer Center) In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers at The University of Texas MD Anderson Cancer Center found that more than half of the women who took the PARP inhibitor talazoparib once daily prior to surgery had no evidence of disease at the time of surgery. If further validated in larger, confirmatory trials, the oral medication could replace chemotherapy for these patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

New approach to immunotherapy leads to complete response in breast cancer patient
(NIH/National Cancer Institute) A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI's Center for Cancer Research (CCR), and the findings were published June 4, 2018 in Nature Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

ASCO & NEJM: AI plus ovarian suppression yields benefit in high-risk younger breast cancer patients
(Dana-Farber Cancer Institute) Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase inhibitor plus ovarian function suppression may gain 10 to 15 percent improvement in freedom from distant recurrence at eight years, according to a new clinical trial analysis reported at the annual meeting of the American Society of Clinical Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news

5,000 British breast cancer patients per year could be spared chemotherapy by taking a daily pill
A landmark study in New York has found that a significant proportion of women with the disease need only a daily pill – such as tamoxifen – to stop their cancer returning after surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

WATCH: Nearly 70 percent of early breast cancer patients may not need chemotherapy: Study
The trial used a gene test done on tumors to help decide whether a woman would benefit from chemo or if they could receive hormone therapy. (Source: ABC News: Health)
Source: ABC News: Health - June 3, 2018 Category: Consumer Health News Tags: WNT Source Type: news

Roche reports disappointing cancer trials
Two Roche oncology drugs provided only modest protection from disease progression in lung cancer and breast cancer, according to data from separate clinical trials. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 3, 2018 Category: Pharmaceuticals Source Type: news

Chemo Not Needed for Most Early Breast Cancer: TAILORx Chemo Not Needed for Most Early Breast Cancer: TAILORx
Practice-changing results from the TAILORx trial have confirmed that about 70% of patients with hormone-positive early breast cancer will not benefit from adjuvant chemotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 3, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Many women with common breast cancer can safely skip chemo, study says
About 70% of women diagnosed with the early stages of one of the most common form of breast cancer may no longer need chemotherapy as part of their treatment, according to the results of a large clinical trial. (Source: CNN.com - Health)
Source: CNN.com - Health - June 3, 2018 Category: Consumer Health News Source Type: news

Genetic Test Can Rule Out Chemo Use in Early Breast Cancer
(MedPage Today) -- Most women can get endocrine therapy alone based on Oncotype Dx results (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 3, 2018 Category: Hematology Source Type: news

Landmark breast cancer study suggests major change to treatment
The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the U.S. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 3, 2018 Category: Consumer Health News Source Type: news

Many breast cancer patients can skip chemo, big U.S. study finds
Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk. (Source: CBC | Health)
Source: CBC | Health - June 3, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Gene Test May Allow Many With Early Breast Cancer to Avoid Chemo
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 3, 2018 Category: Cancer & Oncology Tags: Gynecology, Nursing, Oncology, Research, News, Source Type: news

Most Women With Breast Cancer Can Skip Chemo, According to New Study
(CHICAGO) — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient’s risk. The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the United States and many more elsewhere the ordeal and expense of these drugs. “The impact is tremendous,” said the study leader, Dr. Joseph Sparano of Montefiore Medical Center in New York. Most women in this ...
Source: TIME: Science - June 3, 2018 Category: Science Authors: Marilynn Marchione / AP Tags: Uncategorized healthytime onetime Women's Health Source Type: news

Most Women With Breast Cancer Can Skip Chemo, According to New Study
(CHICAGO) — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient’s risk. The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the United States and many more elsewhere the ordeal and expense of these drugs. “The impact is tremendous,” said the study leader, Dr. Joseph Sparano of Montefiore Medical Center in New York. Most women in this ...
Source: TIME: Health - June 3, 2018 Category: Consumer Health News Authors: Marilynn Marchione / AP Tags: Uncategorized healthytime onetime Women's Health Source Type: news

Breast cancer treatment: More women may avoid chemotherapy thanks to breakthrough research
BREAST cancer symptoms include a lump on the breast or a change in the breast ’s size. Treatment includes surgery, radiotherapy and chemotherapy. However, new research published yesterday has suggested chemotherapy could be avoided by many women. (Source: Daily Express - Health)
Source: Daily Express - Health - June 3, 2018 Category: Consumer Health News Source Type: news

Breast cancer treatment: More women could avoid chemotherapy
BREAST cancer symptoms include a lump on the breast or a change in the breast ’s size. Treatment includes surgery, radiotherapy and chemotherapy. However, new research published yesterday has suggested that many women could avoid this treatment. (Source: Daily Express - Health)
Source: Daily Express - Health - June 3, 2018 Category: Consumer Health News Source Type: news

PI3K Inhibitor Has Mixed Results in Advanced Breast Cancer
(MedPage Today) -- Modest progression benefit, but substantial side effects, with taselisib (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 3, 2018 Category: Hematology Source Type: news

TAILORx Trial Finds Most Women with Early Breast Cancer Do Not Benefit from Chemotherapy
RELEASE ISSUED BY: THE NATIONAL CANCER INSTITUTE AND ECOG-ACRIN CANCER RESEARCH GROUP (Source: Einstein News)
Source: Einstein News - June 3, 2018 Category: Universities & Medical Training Source Type: news

Many breast cancer patients can skip chemo, landmark study finds
The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the U.S. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 3, 2018 Category: Consumer Health News Source Type: news

Many breast cancer patients can skip chemo, big study finds
The largest study ever done of breast cancer treatment finds that most women with the most common form of the disease can skip chemotherapy without hurting their chances of beating the cancer (Source: ABC News: Health)
Source: ABC News: Health - June 3, 2018 Category: Consumer Health News Tags: Health Source Type: news

Breast cancer study set to free women from chemotherapy
Trials find no benefit from gruelling treatment for most patients diagnosed in early stages of disease (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 3, 2018 Category: Pharmaceuticals Source Type: news

Many women with early-stage breast cancer can skip chemotherapy: study
CHICAGO (Reuters) - Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S. researchers said on Sunday. (Source: Reuters: Health)
Source: Reuters: Health - June 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

For Some Breast Cancer Patients, The Chemo Decision Just Got Easier
Thousands of breast cancer patients could now safely avoid chemotherapy thanks to a major study of women with moderate risk of recurrence.(Image credit: Lester Lefkowitz/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - June 3, 2018 Category: Consumer Health News Authors: Sara Kiley Watson Source Type: news

Breast cancer: Test means fewer women will need chemotherapy
From Monday, about 70% of women with early stage cancer may be able to avoid the gruelling treatment. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 3, 2018 Category: Consumer Health News Source Type: news

Good News for Women With Breast Cancer: Many Don ’ t Need Chemo
Many women with early-stage forms of the disease can forego chemo, based on a test that measures the activity of genes involved in breast cancer recurrence. (Source: NYT Health)
Source: NYT Health - June 3, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Breast Cancer Chemotherapy Tumors Hormones Tamoxifen (Drug) American Society of Clinical Oncology Genomic Health Inc Tests (Medical) Source Type: news

TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy
The new data will help inform treatment decisions for many women with early-stage breast cancer. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 3, 2018 Category: American Health Source Type: news

Many Breast Cancer Patients Can Safely Skip Chemo, Large Trial Confirms
The public health implications are huge. If we give chemotherapy only to breast cancer patients at high risk for recurrence, we can avoid overtreating. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 3, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NASDAQ:GHDX Source Type: news

Gene Test May Allow Many With Early Breast Cancer to Avoid Chemo
SUNDAY, June 3, 2018 -- A majority of women with an early form of a common breast cancer may be able to skip chemotherapy, depending on the results of a comprehensive gene test. The new study of nearly 7,000 women found that use of the already... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 3, 2018 Category: General Medicine Source Type: news

TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy
(ECOG-ACRIN Cancer Research Group) " Before TAILORx, there was uncertainty about the best treatment for women with a mid-range score of 11-25 on the Oncotype DX Breast Recurrence Score test. The trial was designed to address this question, and provides a very definitive answer, " said lead investigator Joseph A. Sparano, MD. " Any woman with early-stage breast cancer 75 years or younger should have the 21-gene expression test and discuss the results with her doctor to guide her decision to the right therapy. " (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2018 Category: International Medicine & Public Health Source Type: news

Landmark study finds more breast cancer patients can safely forgo chemotherapy
(Loyola University Health System) A 21-gene test performed on tumors could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study published in the New England Journal of Medicine.Loyola Medicine oncologist Kathy Albain, M.D., is among the main co-authors of the study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2018 Category: International Medicine & Public Health Source Type: news

Gene Test May Allow Many With Early Breast Cancer to Avoid Chemo
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 3, 2018 Category: Cancer & Oncology Source Type: news

Ambry Genetics in Collaboration with Mayo Clinic and NorthShore...
Ambry’s polygenic risk score (PRS) can provide clinicians with individualized breast cancer risk estimates(PRWeb June 03, 2018)Read the full story at https://www.prweb.com/releases/2018/06/prweb15531043.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2018 Category: Pharmaceuticals Source Type: news

Gene Test May Allow Many With Early Breast Cancer to Avoid Chemo
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 3, 2018 Category: Cancer & Oncology Source Type: news

Taselisib Hits, but Barely Slows, PI3KCA-Mutated Breast Cancer Taselisib Hits, but Barely Slows, PI3KCA-Mutated Breast Cancer
The investigational targeted therapy is somewhat effective, but has the downside of significant additional toxicity.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 2, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Taselisib Modestly Delays Progression in ER+ Breast Cancer
Bryant FurlowJun 2, 2018The PI3K inhibitor taselisib offered less dramatic clinical benefits than anticipated, and with significant toxicities. (Source: CancerNetwork)
Source: CancerNetwork - June 2, 2018 Category: Cancer & Oncology Authors: A Source Type: news

Trial Breast Cancer Drug Shows 'Modest' Benefit
As the researchers explained, taselisib has already proven beneficial for people fighting head-and-neck cancers or certain gynecological tumors. Would it do the same for hormone-sensitive breast cancers? (Source: WebMD Health)
Source: WebMD Health - June 2, 2018 Category: Consumer Health News Source Type: news

Roche drugs show limited benefit in lung, breast cancer trials
CHICAGO (Reuters) - In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung cancer and breast cancer, according to data from separate clinical trials presented on Saturday. (Source: Reuters: Health)
Source: Reuters: Health - June 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Experimental Drug, Taselisib, Shows'Modest' Benefit in Slowing Advanced Breast Cancer
SATURDAY, June 2, 2018 -- A new and highly targeted drug slowed the growth of advanced breast cancers by about an average of two months, researchers report. " The findings in this study show a modest benefit to a subgroup of women with estrogen... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 2, 2018 Category: General Medicine Source Type: news

Experimental Drug Shows'Modest' Benefit in Slowing Advanced Breast Cancer
SATURDAY, June 2, 2018 -- A new and highly targeted drug slowed the growth of advanced breast cancers by about an average of two months, researchers report. " The findings in this study show a modest benefit to a subgroup of women with estrogen... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 2, 2018 Category: General Medicine Source Type: news

Experimental Drug Shows 'Modest' Benefit in Slowing Advanced Breast Cancer
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 2, 2018 Category: Cancer & Oncology Source Type: news